Article
Genetic Approaches To Identifying Novel Osteoporosis Drug Targets
1 Apr 2015
Abstract excerpt
During the past two decades effective drugs for treating osteoporosis have been developed, including anti-resorptives inhibiting bone resorption (estrogens, the SERM raloxifene, four bisphosphonates, RANKL inhibitor denosumab) and the anabolic bone forming daily injectable peptide teriparatide. Two potential drugs (odanacatib and romosozumab) are in late stage clinical development. The most pressing unmet need is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
